|
|
The 2nd World Congress on
Controversies in Ophthalmology (COPHy)
Catalonia Palace of Congresses, Barcelona, Spain, March 3-6, 2011 |
|
 |
| Scientific Program |
 |
|
|
| Hall A |
|
|
08:30-10:00 |
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits I |
| Chairpersons: |
G. Rose, UK & R. Medel, Spain |
| Capsule: |
Diagnosis and treatment of lacrimal system abnormalities are still under debate
|
| |
Welcome: G. Rose, UK
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Debate: Dacryocystography has almost no role in the routine assessment of lacrimal drainage problems
Pro
D. Verity, UK
Con
J. Prat Bartomeu, Spain
Discussion
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Debate: Integrated (porous) orbital implants have no measurable advantage in socket surgery
Pro
G. Rose, UK
Con
R. Guthoff, Germany
Discussion
|
| 09:30-10:00 |
Short Debates
1) Implants should be placed at the time of primary evisceration for infective endophthalmitis
2) Endoscopic brow-lifts are of doubtful value and have poor long-term outcome
3) There is no role of biocorporal flaps in the surgery for soley orbital disease
4) Artificial eyes should be removed daily for cleaning, rather than being left for long periods without attention
Moderator:
N. Rosen, Israel
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
R. Medel, Spain
G. Rose, UK
J. Prat-Bartomeu, Spain
W. van den Bosch, The Netherlands
D. Verity, UK
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00
(Hall A)
Chairpersons:
10:30-10:45
10:45-11:00
11:00-11:15
11:15-11:30
11:30-11:45
11:45-12:00
|
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
A. Loewenstein, Israel & S. Lightman, UK
Lecture: More to ME than meets the eye
J. Ambati, USA
Lecture: SCORE
N. Bressler, USA
Lecture: BRAVO
A. Augustin, Germany
Lecture: GENEVA
F. Bandello, Italy
Lecture: Analyzing apples to apples in clinical trials - introducing the rationale for COMO
A. Loewenstein, Israel
Lecture: Perspectives of steroids in the management of ME
S. Lightman, UK
|
| 12:00-13:00 |
Lunch Break |
| |
|
|
13:00-14:30 |
Glaucoma I |
| Chairpersons: |
A. Heijl, Sweden & H.D. Jampel, USA |
| Capsule: |
Preferred glaucoma screening methods
|
|
13:00-13:30
13:00-13:10
13:10-13:20
13:20-13:30 |
Debate: Selective perimetry is often useful
Yes
D. Friedman, USA
No
A. Heijl, Sweden
Discussion
|
|
13:30-14:00
13:30-13:40
13:40-13:50
13:50-14:00 |
Debate: Screening for glaucoma
Justified
D. Friedman, USA
Not justified
H.D. Jampel, USA
Discussion
|
|
14:00-14:30
14:00-14:10
14:10-14:20
14:20-14:30 |
Debate: IOP fluctuation
Important
H.D. Jampel, USA
Not important
A. Heijl, Sweden
Discussion
|
| 14:30-15:00 |
Coffee Break |
| |
|
|
15:00-16:30 |
Glaucoma II |
| Chairpersons: |
D. Friedman, USA & A. Heijl, Sweden |
| Capsule: |
Various treatment modalities in glaucoma - still under debate
|
|
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30 |
Debate: Preperimetric glaucoma
Treat
L. Rossetti, Italy
Don't treat
G. Sunaric Megevand, Switzerland
Discussion
|
|
15:30-16:00
16:00-16:10
16:10-16:20
16:20-16:30 |
Debate: First-line treatments in open-angle glaucoma
Trabeculectomy – surgical intervention
H.D. Jampel, USA
SLT
S. Melamed, Israel
Other
P. Foster, UK
|
|
16:00-16:30
16:00-16:10
16:10-16:20
16:20-16:30 |
Debate: Treatment of closed angle glaucoma
Iridotomy
D. Friedman, USA
Cataract extraction
P. Foster, UK
Discussion
|
|
16:30-18:00 |
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits II |
| Chairpersons: |
G. Rose, UK & D. Verity, UK |
| Capsule: |
Debates related to orbital disease
|
| |
Welcome: G. Rose, UK & D. Verity, UK
|
|
16:30-17:00
16:30-16:40
16:40-16:50
16:50-17:00 |
Debate: Oral antibiotics are now the primary treatment of choice for infective orbital cellulitis
Yes
W. ven den Bosch, The Netherlands
No
M. Gonzalez-Candial, Spain
Discussion
|
|
17:00-17:30
17:00-17:10
17:10-17:20
17:20-17:30 |
Debate: Pleomorphic adenomas should be biopsied as they can be removed without complication
Yes
N. Rosen, Israel
No
R. Hermida, Spain
Discussion
|
|
17:30-18:00 |
Short Debates
1) Lacrimal sac abcesses should be drained and DCR deferred until inflammation settles
2) Orbital wall fractures should generally have early repair
3) Silicone rods are the preferred brow suspension material for patients with severe myopathic ptosis
4) Anti-metabolites should routinely be used during revisional lacrimal drainage surgery
5) DCR is a nasal operation and should be performed by ENT surgeons!
Moderator:
R. Medel, Spaihn
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
J. Prat-Bartomeu, Spain
G. Rose, UK
N. Rosen, Israel
W. van den Bosch, The Netherlands
D. Verity, UK
|
| Hall B |
|
|
08:30-10:00 |
Pediatrics I: Strabismus |
| Chairpersons: |
P. Nucci, Italy & K.K. Nischal, UK |
| Capsule: |
Questionable strabismus treatment modalities
|
| 08:30-09:15 |
Panel Discussion: Accommodative Estropia
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
|
| 09:15-10:00 |
Panel Discussion: Brown Syndrome and Duane Syndrome
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00
(Hall A) |
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology |
| 12:00-13:00 |
Lunch Break |
| |
|
|
13:00-14:30 |
Trauma I |
| Chairpersons: |
F. Kuhn, USA & J. Moisseiev, Israel |
| Capsule: |
Ocular trauma treatment
|
|
13:00-13:45
13:00-13:10
13:10-13:20
13:20-13:30
13:30-13:45 |
Update Lectures
Traumatic optic neuropathy: Management, neuroprotection, regeneration
N. Miller, USA
Shaken baby syndrome: Ocular and associated systemic findings, medical and surgical management, amblyopia prevention
W. Schrader, Germany
Surgical options for reconstruction after traumatic cataract repair
D. Sachs, Israel
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany
|
|
13:45-14:30
13:45-14:00
14:00-14:15
14:15-14:30 |
Debate: Enucleation and evisceration in the management of severe eye injury
Pro: Removal of the globe is essential
N. Rosen, Israel
Con: The globe should be preserved
F. Kuhn, USA
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany |
| 14:30-15:00 |
Coffee Break |
| |
|
|
15:00-16:30 |
Trauma II |
| Chairpersons: |
J. Moisseiev, Israel & F. Kuhn, USA |
| Capsule: |
Specific situations in ocular trauma
|
|
15:00-15:45
15:00-15:15
15:15-15:30
15:30-15:45 |
Update Lectures
Traumatic macular hole
J. Moisseiev, Israel
Combined anterior and posterior trauma
P. Sternberg, USA
Discussion
|
| 15:45-16:30 |
Case Presentation and Panel Discussion: Anterior and posterior segment
Moderators:
J. Moisseiev, Israel & F. Kuhn, USA
Panel:
A. Barak, Israel
W. Mieler, USA
W. Schrader, Germany
P. Sternberg, USA
|
| Hall C |
|
|
08:30-10:00 |
Cataract: Complicated Situations in Cataract Sugery I |
| Chairpersons: |
W.J. Stark, USA & E. Assia, Israel |
| Capsule: |
Cataract surgery: Problems still to be solved
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Debate: IFIS: Surgical thrill or no big deal?
No more than some minor modifications
R. Barraquer, Spain
Hooks, OVDs and low settings
Z. Biro, Hungary
Discussion
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Debate: Astigmatism correction should be performed during lens surgery or not?
Toric IOL
J. Alio, Spain
Yes, there are
G. Kymionis, Greece
Discussion
|
|
09:30-09:45
09:45-10:00 |
Lecture: Cataract surgery: Does it increase AMD progression or not?
W.J. Stark, USA
Lecture: Femtosecond laser cataract surgery
J. Alio, Spain
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00
|
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
|
| 12:00-13:00 |
Lunch Break |
| |
|
|
13:00-14:30 |
Medical Retina I |
| Chairpersons: |
G. Coscas, France & F. Bandello, Italy |
| Capsule: |
AMD - Lucentis? Avastin? VEGF trap? Others?
|
|
13:00-13:30
13:00-13:10
13:10-13:20
13:20-13:30
|
Debate: The role of adjunctive treatment in AMD treatment
Adjunctive therapy is not needed
E. Souied, France
Adjunctive therapy (e.g. PDT, brachytherapy) - maybe helpful
A. Augustin, Germany
Radiation adjunctive therapy may be helpful
P. Dugel, USA
Panel Discussion
Moderator:
U. Chakravarthy, UK
Panel:
E. Basauri, Spain
G. Coscas, France
P. Dugel, USA
A. Loewenstein, Israel
G. Soubrane, France
|
|
13:30-14:00
13:30-13:38
13:38-13:46
13:46-13:53
13:53-14:00 |
Debate: Avastin vs. Lucentis vs. others
Avastin: What evidence is available?
P. Lanzetta, Italy
What about VEGF-trap?
U. Schmidt-Erfurth, Austria
New players in the game
G. Soubrane, France
Panel Discussion
Moderator:
N. Bressler, USA
Panel:
F. Boscia, Italy
U. Chakravarthy, UK
P. Dugel, USA
|
|
14:00-14:30
14:00-14:07
14:07-14:15
14:15-14:23
14:23-14:35 |
Debate: Optimal treatment for CNV secondary to AMD
Monthy anti VEGF
S. Bressler, USA
PRN anti VEGF
F. Bandello, Italy
Panel Discussion
Moderator:
S. Bressler, USA
Panel:
U. Chakravarthy, UK
P. Dugel, USA
P. Lanzetta, Italy
A. Loewenstein, Israel
G. Soubrane, France
|
| 14:00-14:30 |
Coffee Break |
| |
|
|
15:00-16:30 |
Cataract: Complicated Situations in Cataract Surgery II |
| Chairpersons: |
E. Assia, Israel & W.J. Stark, USA |
| Capsule: |
Premium IOLs: Advantages and concerns
|
|
15:00-15:30
15:00-15:15
15:15-15:25
15:25-15:30 |
Debate: Management of cases with weak zonules
Iris fixation technique
W.J. Stark, USA
Capsular anchor
E. Assia, Israel
Discussion
|
|
15:30-16:00
15:30-15:40
15:40-15:50
15:50-16:00 |
Debate: Premium lens
Accommodative IOLs
J. Alio, Spain
Multifocal IOLs
W.J. Stark, USA
Discussion
|
|
16:00-16:30 |
Panel Discussion: The premium IOL patient: Happy or unhappy?
Moderator: E. Assia, Israel
Panel:
J. Alio, Spain
Z. Biro, Hungary
G. Kymionis, Greece
W.J. Stark, USA
|
| Hall A |
|
|
08:30-10:00 |
Tumors I
|
| Chairpersons: |
L. Zografos, Switzerland & J. Pe'er, Israel |
| Capsule: |
Iris tumors - diagnostic and therapeutic considerations |
| |
|
|
08:30-08:50
08:30-08:38
08:38-08:46
08:46-08:50
|
Debate: Incisional biopsy of the iris
Pro
L. Desjardins, France
Con
N. Bechrakis, Austria
Discussion |
|
08:50-09:10
08:50-08:58
08:58-09:06
09:06-09:10 |
Debate: Therapeutic approach to iris melanomas
Primary surgery
T. Kivela, Finland
Primary irradiation
B. Damato, UK
Discussion
|
|
09:10-09:30
09:10-09:18
09:18-09:26
09:26-09:30 |
Debate: Circumscribed vs. Global irradiation of anterior segment in iris melanomas
Circumscribed irradiation
L. Desjardins, France
Global irradiation of anterior segment
L. Zografos, Switzerland
Discussion
|
| 09:30-10:00 |
Controversies in the diagnostic approach and management of iris tumors
Discussion on selected Case Reprots
Presenter:
L. Zografos, Swizterland
Discussant:
J. Pe'er, Israel
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00 |
Socioeconomics |
| Chairperson: |
N. Bressler, USA |
| Capsule: |
Ethical concerns
|
|
10:30-11:00
10:30-10:40
10:40-10:50
10:50-11:00 |
Part I
Lecture: Is participation in speakers' bureaus unprofessional conduct for physicians who proivde continuing medical education?
N. Bressler, USA
Lecture: An editor’s viewpoint: Conflict of interest and other quandaries
H.D. Jampel, USA
Discussion
|
|
11:00-11:30
11:30-11:40
11:40-11:50
11:50-12:00 |
Part II
Lecture: Pros and Cons regarding industry interactions with physicians in clinical research
N. Bressler, USA
Lecture: Characteristics and impact of the diffusion of medical technologies
G. Barbash, Israel
Discussion |
| |
|
|
12:00-13:00
(Garden Pavilion)
12:10-12:20
12:20-12:30
12:30-12:40
12:40-12:50
12:50-13:00 |
Glaucoma: A neurodegenerative disease
Lunch Session
Lecture: Glaucoma - a neurodegenerative disease
L. Levin, Canada
Lecture: Measuring of glaucoma progression
A. Heijl, Sweden
Lecture: Managing IOP - the most important risk factor
L. Rossetti, Italy
Lecture: What to do when IOP lowering isn't enough
S. Gandolfi, Italy
Lecture: Mechanisms behind therapeutic outcomes
F. Cordeiro, UK
|
| |
|
|
13:00-14:30 |
Glaucoma III
|
| Chairpersons: |
S. Gandolfi, Italy & L. Rossetti, Italy |
| Capsule: |
Hot glaucoma topics in the pipeline
|
|
13:00-13:30
13:00-13:10
13:10-13:20
13:20-13:45 |
Debate: Medical Management of Glaucoma - Neuroprotection
Neuroprotection is a viable 1st line option for glaucoma management
L. Levin, Canada
Neuroprotection should not be part of glaucoma management
F. Cordeiro, UK
Panel Discussion on NP: To be or not to be taht is the Question
Moderator: L. Rossetti, Italy
Panel:
F. Cordeiro, UK
L. Levin, Canada
|
|
13:45-14:30
13:45-13:55
13:55-14:05
14:05-14:30 |
Debate: Structure and Function in Measuring rate of progression in Glaucoma
Imaging is the easiest and most cost effective way for following glaucoma progression
TBA
Performing imaging or photography in manifest glaucoma is a waste of resources - instead monitoring using visual fields should be done more often
L. Rossetti, Italy
Panel Discussion
Moderator: A. Heijl, Sweden
Panel:
H.D. Jampel, USA
S. Kurtz, Israel
L. Rossetti, Italy
|
| |
|
| 14:30-15:00 |
Coffee Break |
| |
|
|
15:00-16:30
|
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
|
| Moderator: |
A. Cruess, Canada
Lecture: European regulation and the practicing ophthalmologist
P. Bogaert, Belgium
Lecture: The regulatory process in action: A case study
K. Khunti, UK
Lecture: Understanding the safety profile of anti-VEGF's
P. Kaiser, USA
Debate: Off label prescribing, patient safety and the current environment
Panel & audience
Summary
Moderator |
| |
|
|
16:30-18:00 |
Neuro-Ophthalmology I |
| Chairpersons: |
N. Miller, USA & M. Burdon, UK |
| Capsule: |
Optic neuropathy |
| |
|
| 16:30-17:15 |
Symposium on the treatment of traumatic optic neuropathy
Steroids should be used
A. Lee, USA
Steroids should not be used
A. Arnold, USA
Surgery should be performed
N. Miller, USA
Observation is best
M. Burdon, UK
|
| 17:15-18:00 |
Case Presentations
1) Acute isolated 6th nerve palsy in an elderly vasculopath
A. Arnold, USA
A. Kesler, Israel
2) Ocular migraine
A. Arnold, USA
3) Acute 3rd nerve palsy
A. Arnold, USA
B. Sanchez Dalmau, Spain
4) Acquired nystagmus in a patient with MS
M. Burdon, UK
5) A patient with IIH and transverse sinus stenosis
L. Castillo, Spain
A. Lee, USA
6) A patient with double vision from GCA
A. Kesler, Israel
S. Muñoz, Spain
7) A patient with long-standing optic atrophy
Open panel
|
| Hall B |
|
|
08:30-10:00 |
Imaging I |
| Chairpersons: |
H. Scholl, USA & G. Staurenghi, Italy |
| Capsule: |
Fundus autofluorescence and beyond
|
|
08:30-09:15
08:30-08:45
08:45-09:00
09:00-09:15 |
Debate: Role of autofluorescence for monitoring progression of geographic atrophy in AMD?
Pro
E. Midena, Italy
Con
U. Chakravarthy, UK
Discussion
|
|
09:15-10:00
09:15-09:30
09:30-09:45
09:45-10:00 |
Lecture Series: Beyond conventional autofluorescence
Near-infrared autofluorescence
C. von Strachwitz, Germany
Confocal blue reflectance and two-wavelengh fundus autofluorescence
P. Charbel Issa, UK
Discussion
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00 |
Imaging II |
| Chairpersons: |
G. Staurenghi, Italy & H. Scholl, USA |
| Capsule: |
High-resolution optical coherence tomography
|
|
10:30-11:15
10:30-10:45
10:45-11:-00
11:00-11:15 |
Debate: Is SD-OCT necessary and sufficient to guide clinical decisions in neovascular AMD or diabetic macular edema?
Yes
U. Schmidt-Erfurth, Austria
No
J. Mones, Spain
Discussion
|
|
11:15-12:00
11:15-11:30
11:30-11:45
11:45-12:00 |
Lecture Series: Combining SD-OCT with other imaging and functional technologies
SD-OCT and confocal reflectance imaging - evidence to support the combination
G. Staurenghi, Italy
Structure function-correlation of the central human retina
H. Scholl, USA
Disucssion
|
|
12:00-13:00
(Garden Pavilion) |
Glaucoma: A neurodegenerative disease
Lunch Session
|
| |
|
|
13:00-14:30 |
Refractive Surgery |
| Chairpersons: |
J. Alio, Spain |
| Capsule: |
Upper limits of corneal refractive surgery in myopia and hyperopia will be debated and discussed
|
|
13:00-13:45
13:00-13:15
13:15-13:30
13:30-13:45 |
Debate: Stretching the limits of excimer laser surgery: Lasik in high myopia, high hyperopia
High myopia
G. Kymionis, Greece
High hyperopia
D. de Ortueta, Germany
Discussion
|
|
13:45-14:30 |
Panel Discussion: Lens based refractive surgery
Moderator:
J. Alio, Spain
Panel:
D. de Ortueta, Germany
G. Kymionis, Greece
C. Verges, Spain
|
| 14:30-15:00 |
Coffee Break |
| |
|
|
(Hall A) |
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis |
| |
|
|
16:30-18:00 |
Medical Retina II |
| Chairpersons: |
F. Bandello, Italy & A. Augustin, Germany |
| Capsule: |
Vein occlusion and diabetic retinopathy
|
|
16:30-17:15
16:30-16:45
16:45-17:00
17:00-17:15 |
Debate: What is the first-line treatment of macular edema in retinal vein occlusion?
Corticosteroids
J. Mones, Spain
Anti-VEGF therapy
S. Bressler, USA
Panel Discussion:
1) How should me classify DME?
2) If we initiate anti-VEGF therapy for DME, should it be conbined with laser initially?
Moderator:
J. Mones, Spain
Panel:
S. Bressler, USA
B. Corcostegui, Spain
A. Pollack, Israel
G. Soubrane, France
|
|
17:15-18:00
17:15-17:30
17:30-17:45
17:45-18:00 |
Debate: What is the first-line treatment of macular edema in diabetic macular edema?
Corticosteroids
A. Augustin, Germany
Anti- VEGF therapy
N. Bressler, USA
Panel Discussion:
Moderator:
J. Cunha-Vaz, Portugal
Panel:
B. Corcostegui, Spain
B. Eldem, Turkey
A. Loewenstein, Israel
U. Schmidt-Erfurth, Austria
G. Soubrane, France
|
| Hall C |
|
|
08:30-10:00 |
Cornea I |
| Chairpersons: |
J. Alio, Spain & W.J. Stark, USA |
| Capsule: |
Corneal ulcers
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Debate: Bacterial Corneal Ulcers
No need to culture
G. Kymionis, Greece
Culture is necessary
R. Barraquer, Spain
Disucssion
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Debate: First-line treatment in corneal ulcer
4th generation flouroquinolones
TBA
Fortified antibiotics
J.P. Alvarez de Toledo, Spain
Discussion
|
| 09:30-10:00 |
Panel Discussion: Acanthameba infection
Moderator: J. Alio, Spain
Panel:
J.P. Alvarez de Toledo, Spain
R. Barraquer, Spain
G. Kymionis, Greece
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:00 |
Uveitis |
| Chairpersons: |
S. Lightman, UK & P. Sternberg, USA |
| Capsule: |
JRA, ARN
|
|
10:30-11:00
10:30-10:40
10:40-10:50
10:50-11:00
|
Debate: Juvenile idiopathic arthritis
Phaco/IOL
S. Taylor, UK
Lensectomy vitrectomy
M. de Smet, The Netherlands
Discussion
|
|
11:00-11:30
11:00-11:10
11:10-11:20
11:20-11:30 |
Debate: Treatment of ARN?
Update of current medical treatment
S. Lightman, UK
The importance of surgical treatment, including laser
P. Sternberg, USA
Panel Discussion
Moderator:
S. Lightman, UK
Panel:
D. Jabs, USA
M. Kramer, Israel
P. Sternberg, USA
S. Taylor, UK
|
|
11:30-12:00
11:30-11:40
11:40-11:50
11:50-12:00 |
Debate: Mucous membrane pemphigoid: Treatment
Early cyclophosphamide
D. Jabs, USA
Stepped approach
M. Kramer, Israel
Discussion
|
|
12:00-13:00
|
Glaucoma: A neurodegenerative disease
Lunch Session
|
| |
|
|
13:00-14:30 |
Pediatrics II: Pediatric Ophthalmology
|
| Chairpersons: |
K.K. Nischal, UK & P. Nucci, Italy
|
| Capsule: |
Controversies in pediatric external and anterior segment disease
|
|
13:00-13:45
|
Panel Discussion: Controversies in pediatric anterior segment surgery
Panel:
D. Bremond-Gignac, France
M. Morales Ballus, Spain
A. Serra Castanera, Spain
|
|
13:45-14:30
|
Panel Discussion: External disease
Panel:
D. Bremond-Gignac, France
J. Prat-Bartomeu, Spain
A. Serra Castanera, Spain |
|
|
|
| 14:30-15:00 |
Coffee Break |
| |
|
|
15:00-16:30
(Hall A)
|
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis |
| |
|
|
16:30-18:00 |
Cornea II |
| Chairpersons: |
W.J. Stark, USA & J. Alio, Spain |
| Capsule: |
Modern keratoplasty techniques
|
|
16:30-17:00
16:30-16:40
16:40-16:50
16:50-17:00 |
Debate: Femtosecond keratoplasty: Is it worthwhile?
Yes
G. Baikoff, France
No
TBA
Discussion
|
| 17:00-17:10 |
Lecture: Fuchs' Dystrophy and cataract: Cataract surgery alone or combined with endothelial replacement?
|
| 17:10-17:35 |
Panel Discussion: Best method for keratoplasty - DSAEK, DMED, Descement menbrane keratoplasty or deep lameller keratoplasty?
Moderator:
W.J. Stark, USA
Panel:
J. Alio, Spain
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
|
| 16:35-18:00 |
Panel Discussion: Keratoprosthesis (Dohlman, Osteodental, Australian)
Moderator:
J. Alio, Spain
Panel:
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
|
| Hall A |
|
|
08:30-10:00 |
Tumors II |
| Chairpersons: |
J. Pe'er, Israel & L. Zografos, Switzerland |
| Capsule: |
Conjunctival tumors - diagnostic and therapeutic considerations |
| |
|
|
08:30-08:50
08:30-08:38
08:38-08:46
08:46-08:50
|
Debate: Ocular surface squamous neoplasia (OSSN) - How to treat?
Always excision, with or without additional treatment
N. Bechrakis, Austria
Topical chemotherapy as primary treatment
J. Pe'er, Israel
Discussion
|
|
08:50-09:10
08:50-08:58
08:58-09:06
09:06-09:10
|
Debate: Primary acquired melanosis: Definition and approach
PAM is adequate and biopsy is unnecessary
T. Kivela, Finland
PAM is inadequate and biopsy is required
B. Damato, UK
Discussion
|
|
09:10-09:30
09:10-09:18
09:18-09:26
09:26-09:30 |
Debate: Large conjunctival melanoma - How to treat?
Excision & additional treatment
B. Damato, UK
External beam radiation - proton/photon
L. Desjardins, France
Discussion
|
| 09:30-10:00 |
Controversies in the diagnostic approach and management of conjunctival tumors
Interesting cases with possible controversial approaches
Presenter:
J. Pe'er, Israel
Discussant:
L. Zografos, Switzerland
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:30 |
Neuro-Ophthalmology II |
| Chairpersons: |
N. Miller, USA & M. Burdon, UK |
| Capsule: |
Treatment issues
|
| 10:30-11:15 |
Point-Counterpoint: Medical Therapy in Neuro-ophthalmologic disorders
1) Should patients with NAION be treated with steroids?
Yes
A. Lee, USA
No
A. Arnold, USA
2) Should steroids be the first-line drug for patients with ocular myastenia gravis
Yes
N. Miller, USA
No
M. Burdon, UK
3) Should immunomodulary drugs be given to high-risk patients with optic neuritis and white-matter lesions on MR?
Yes
A. Arnold, USA
No
M. Burdon, UK
4) Topamax for IIH patients who cannot tolerate Diamox: Help or hype?
Helps
A. Lee, USA
Hype
M. Burdon, UK
|
| 11:15-12:30 |
Case Presentations
1) OMSM: When do you radiate?
A. Arnold, USA
2) Non-organic visual loss in an adult
A. Kesler, Israel
B. Sanchez-Dalmau, Spain
3) Non-organic visual loss in a child
A. Lee, USA
S. Muñoz, Spain
4) Steroid-dependent optic neuritis
M. Burdon, UK
L. Castillo, Spain
|
| Hall B |
|
|
08:30-10:00 |
Surgical Retina I |
| Moderators: |
A. Augustin, Germany; W. Mieler, USA & J. Moisseiev, Israel; P. Sternberg, USA |
| Capsule: |
Changing trends in vitreo-retinal surgery
|
|
08:30-09:15
08:30-08:45
08:45-09:00
09:00-09:15 |
Debate: Does silicone oil still have a role in complicated RD with PVR?
Pro: Silicone oil is the key to success in these difficult cases
W. Mieler, USA
Con: Silicone oil is not necessary and gas is as effective as silicone
S. Rizzo, Italy
Discussion
|
|
09:15-10:00
09:15-09:30
09:30-09:45
09:45-10:00 |
Debate: Should we perform pneumatic retinopexy?
Pro: Pneumatic retinopexy is a safe and effective treatment for RD
F. Boscia, Italy
Con: Pneumatic retinopexy is dangerous with high failure rate
J. Nawrocki, Poland
Discussion
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
10:30-12:30 |
Surgical Retina II |
| Moderators: |
A. Augustin, Germany; F. Boscia, Italy; W. Mieler, USA & J. Moisseiev, Israel |
| Capsule: |
Macular surgery
|
|
10:30-11:10
10:30-10:45
10:45-11:00
11:00-11:10 |
Debate: Prone positioning after vitrectomy for macular hole: Is it really necessary?
Pro: Prone positioning of at least 5 days is critical for hole closure
J. Nawrocki, Poland
Con: Prone positioning is not necessary
P. Sternberg, USA
Discussion
|
|
11:10-11:50
11:10-11:25
11:25-11:40
11:40-11:50 |
Debate: Should we operate an ERM with good VA and what technique should we use?
Pro: ERM peeling should be performed in eyes with good VA
J. Moisseiev, Israel
Con: ERM peeling should be performed with VA worse than 20/50
W. Meiler, USA
Discussion
|
| 11:50-12:00 |
Case Presentation with Panel Discussion
(2-3 cases)
Presenter:
J. Moisseiev, Israel
Panel:
A. Augustin, Germany
W. Mieler, USA
J. Nawrocki, Poland
P. Sternberg, USA
|
|
|
|
|
WebStudio.co.il